What Does SpringWorks Therapeutics Do?

Total employees396
HeadquartersStamford
Founded2017

SpringWorks Therapeutics is a commercial-stage biopharmaceutical company focused on acquiring, developing, and commercializing life-changing medicines for underserved patient populations suffering from severe rare diseases and cancer. They employ a precision medicine approach, targeting therapies to genetically defined patient populations. Their lead product, OGSIVEOâ„¢ (nirogacestat), is approved for treating adults with desmoid tumors. The company's pipeline includes other programs in various stages of clinical development for oncology and rare diseases.

Where Is SpringWorks Therapeutics's Headquarters?

SpringWorks Therapeutics officeSpringWorks Therapeutics officeSpringWorks Therapeutics officeSpringWorks Therapeutics office
*Images sourced via web search. Rights belong to original owners

HQ Function

The Stamford headquarters serves as the central hub for corporate leadership, strategic planning, research and development oversight, clinical operations management, and commercialization efforts.

Notable Features:

The headquarters is located in a modern office building, likely equipped with facilities that support a dynamic biopharmaceutical company, fostering collaboration and innovation. Specific architectural highlights are not widely publicized.

Work Culture:

The work culture at SpringWorks Therapeutics is characterized by a strong emphasis on scientific excellence, patient-centricity, urgency, and collaboration. As a growing biopharma, it likely fosters an innovative and results-driven environment.

HQ Significance:

The headquarters' location in Stamford provides access to a rich talent pool from the pharmaceutical and biotech industries in the Northeast, as well as proximity to financial markets and key partners.

Values Reflected in HQ: The headquarters likely reflects the company's values of innovation, precision, and a commitment to addressing critical unmet medical needs through a well-organized and collaborative workspace.

Location:

SpringWorks Therapeutics currently has a primary operational focus in the United States for its commercial activities and corporate functions. However, its clinical development programs are global, with trial sites often located across North America, Europe, and potentially other regions to ensure diverse patient enrollment and to support future international regulatory submissions and market access.

Street Address:

100 Washington Blvd, Suite 700

City:

Stamford

State/Province:

CT

Country:

USA

Where Else Does SpringWorks Therapeutics Operate Around the World?

San Diego, California/USA

Address: Specific address not publicly listed for research facility.

To tap into the specialized talent pool and research collaborations available in one of the leading U.S. biotech hubs, focusing on advancing early-pipeline assets.

Buying Intent Signals for SpringWorks Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading SpringWorks Therapeutics? Meet the Executive Team

As of April 2025, SpringWorks Therapeutics' leadership includes:

Saqib Islam - President and Chief Executive Officer
Badreddin Edris, Ph.D. - Chief Operating Officer
Bhaskar Srivastava, M.D., Ph.D. - Chief Financial Officer and Head of Corporate Strategy
L. Mary Smith, Ph.D. - Chief Development Officer
Mike Hannafin - Chief Commercial Officer
Jim Cassidy, J.D., Ph.D. - Chief Business Officer
Tai-An Lin, Ph.D. - Chief Scientific Officer
Chandler Harris - Chief Corporate Affairs Officer

Who's Investing in SpringWorks Therapeutics?

SpringWorks Therapeutics has been backed by several prominent investors over the years, including:

Bain Capital Life Sciences
OrbiMed
Pfizer Ventures
Perceptive Advisors
GSK (GlaxoSmithKline)
ArrowMark Partners
Fidelity Management & Research Company LLC
T. Rowe Price Associates, Inc.

What Leadership Changes Has SpringWorks Therapeutics Seen Recently?

Hire3
Exits0

Over the past 12-18 months, SpringWorks Therapeutics has strengthened its executive team with key appointments like a new CFO and CCO, reflecting its transition into a commercial-stage company. No major high-profile executive exits have been publicly announced during this period.

New Appointments:

Bhaskar Srivastava, M.D., Ph.D., Dr. Srivastava was appointed CFO, bringing significant experience in biotech finance, strategy, and investor relations.
Mike Hannafin, Mike Hannafin joined as CCO to lead commercial strategy and execution as the company prepared for its first product launch.
Chandler Harris, Chandler Harris was appointed as Chief Corporate Affairs Officer, responsible for communications, investor relations, and government affairs.

What Technology (Tech Stack) Is Used bySpringWorks Therapeutics?

Discover the tools SpringWorks Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

SpringWorks Therapeutics Email Formats and Examples

SpringWorks Therapeutics most likely utilizes common corporate email formats. The predominant patterns are typically [first_initial][last]@[companydomain.com] or [first].[last]@[companydomain.com].

flast@springworkstx.com

Format

jsmith@springworkstx.com

Example

90%

Success rate

What's the Latest News About SpringWorks Therapeutics?

SpringWorks Therapeutics Press Release • May 9, 2024

SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

SpringWorks Therapeutics announced its Q1 2024 financial results, highlighting net product revenue from OGSIVEOâ„¢ sales, progress in its clinical pipeline, and upcoming milestones. The company reported $20.3 million in OGSIVEOâ„¢ net product revenue....more

SpringWorks Therapeutics Press Release • November 27, 2023

SpringWorks Therapeutics Announces FDA Approval of OGSIVEOâ„¢ (nirogacestat) for the Treatment of Adults with Desmoid Tumors

The U.S. Food and Drug Administration (FDA) approved OGSIVEOâ„¢ (nirogacestat), an oral gamma-secretase inhibitor, for adult patients with progressing desmoid tumors requiring systemic treatment. This is the first approved therapy for desmoid tumors....more

SpringWorks Therapeutics Press Release • April 3, 2024

SpringWorks Therapeutics Announces Publication of Phase 3 DeFiANT Trial Results for OGSIVEOâ„¢ (nirogacestat) in The New England Journal of Medicine

The pivotal Phase 3 DeFiANT trial results for OGSIVEOâ„¢ (nirogacestat) in patients with desmoid tumors were published in The New England Journal of Medicine, detailing the efficacy and safety data that supported its FDA approval....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including SpringWorks Therapeutics, are just a search away.